Cargando…
Evaluating risk to people with epilepsy during the COVID-19 pandemic: Preliminary findings from the COV-E study
The COVID-19 pandemic has caused global anguish unparalleled in recent times. As cases rise, increased pressure on health services, combined with severe disruption to people’s everyday lives, can adversely affect individuals living with chronic illnesses, including people with epilepsy. Stressors re...
Autores principales: | Thorpe, Jennifer, Ashby, Samantha, Hallab, Asma, Ding, Ding, Andraus, Maria, Dugan, Patricia, Perucca, Piero, Costello, Daniel, French, Jacqueline A., O'Brien, Terence J., Depondt, Chantal, Andrade, Danielle M., Sengupta, Robin, Delanty, Norman, Jette, Nathalie, Newton, Charles R., Brodie, Martin J., Devinsky, Orrin, Helen Cross, J., Sander, Josemir W., Hanna, Jane, Sen, Arjune |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7698680/ https://www.ncbi.nlm.nih.gov/pubmed/33341393 http://dx.doi.org/10.1016/j.yebeh.2020.107658 |
Ejemplares similares
-
Impact of the COVID‐19 pandemic on people with epilepsy: Findings from the US arm of the COV‐E study
por: Dugan, Patricia, et al.
Publicado: (2022) -
Impact of the COVID-19 pandemic on people with epilepsy: Findings from the Brazilian arm of the COV-E study
por: Andraus, Maria, et al.
Publicado: (2021) -
Optimising epilepsy care throughout the Afghan refugee crisis
por: Sen, Arjune, et al.
Publicado: (2021) -
Incidence of Epilepsy and Seizures Over the First 6 Months After a COVID-19 Diagnosis: A Retrospective Cohort Study
por: Taquet, Maxime, et al.
Publicado: (2023) -
FDA safety warning on the cardiac effects of lamotrigine: An advisory from the Ad Hoc ILAE/AES Task Force
por: French, Jacqueline A., et al.
Publicado: (2021)